Sybron moves into diagnostics with acquisitions
This article was originally published in Clinica
Sybron, the US dental specialist Sybron has completed a spate of small acquisitions. In early April, it purchased Alexon Biomedical. Alexon based in Sunnyvale, California, manufactures diagnostic tests for gastro-intestinal infections and expects sales of around $9 million this year. Alexon will be merged with Trend Scientific, which Sybron acquired in January, and Remel, purchased in March.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.